Results 201 to 210 of about 15,165 (218)

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake

Cell Metabolism, 2019
Ambiguity regarding the role of glucose-dependent insulinotropic polypeptide (GIP) in obesity arises from conflicting reports asserting that both GIP receptor (GIPR) agonism and antagonism are effective strategies for inhibiting weight gain.
John A Tadross, Joseph Polex-Wolf, Ilona Zvetkova   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Glucose-Dependent Insulinotropic Polypeptide—A Postprandial Hormone with Unharnessed Metabolic Potential

Annual Review of Nutrition, 2022
Fiona M Gribble, Frank Reimann
exaly  

The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion

Diabetologia, 1987
D R Owens, A J Moody, Stephen D Luzio
exaly  

Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans

Journal of Clinical Endocrinology and Metabolism, 2020
Simon Veedfald, Louise Vedtofte, Kirsa Skov-Jeppesen   +2 more
exaly  

Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)

Vitamins and Hormones, 2009
Christopher H S Mcintosh, Scott B Widenmaier   +1 more
exaly  

The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system

Peptides, 2020
Fiona M Gribble, Frank Reimann
exaly  

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus

Diabetologia, 1989
Stephen D Luzio, T M Hayes, D R Owens
exaly  

Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders

Expert Opinion on Therapeutic Targets, 2018
Mahip K Verma, Kumar V S Nemmani
exaly  

No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects

Peptides, 2020
Michael A Nauck, Jens J Holst, Juris J Meier   +2 more
exaly  

Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction

Cell Metabolism, 2018
John R Ussher, Jonathan E Campbell, Erin E Mulvihill   +2 more
exaly